Clinical Trial Update: uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

View source ↗

Summary

A registry update for the uTRACT Jelmyto Registry, documenting UTUC patients treated with Jelmyto and the study status as Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma
• Urothelial Carcinoma of the Renal Pelvis
• Urothelial Carcinoma of the Ureter

Drugs mentioned

• JELMYTO (MITOMYCIN)

Snippet

Sponsor: UroGen Pharma Ltd. | Conditions: Urothelial Carcinoma, Urothelial Carcinoma Recurrent | Status: RECRUITING